Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.8K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modelling synaptic dysfunction in childhood dementia using human iPSC-derived cortical networks.

Nature communications·2026
Same author

Letter: Ventricular Entry During Glioblastoma Resection is Associated With Reduced Survival and Increased Risk of Distant Recurrence.

Neurosurgery·2025
Same author

A hexamer tandem repeat RNA embedded within an SVA retrotransposon drives R-loop formation and neurodegeneration.

Cell reports·2025
Same author

A hexamer tandem repeat RNA embedded within an SVA retrotransposon drives R-loop formation and neurodegeneration.

Cell reports·2025
Same author

Repurposing trifluoperazine for glioblastoma treatment.

Trends in pharmacological sciences·2025
Same author

Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson's model.

Translational neurodegeneration·2024
Same journal

Driving neuronal apoptosis.

Nature reviews. Neuroscience·2026
Same journal

Using human 3D organoid models to gain mechanistic insight in motor neuron diseases.

Nature reviews. Neuroscience·2026
Same journal

What scrub jays have taught us about the neural intersection of memory and action selection.

Nature reviews. Neuroscience·2026
Same journal

Boundary issues for multidimensional frameworks of representation.

Nature reviews. Neuroscience·2026
Same journal

Reply to 'Boundary issues for multidimensional frameworks of representation'.

Nature reviews. Neuroscience·2026
Same journal

Brain-spleen axis regulates learned fear.

Nature reviews. Neuroscience·2026
See all related articles

Related Experiment Video

Updated: Mar 21, 2026

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
11:42

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

5.5K

Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience.

Jerome Mertens1, Maria C Marchetto1, Cedric Bardy1

  • 1Salk Institute for Biological Studies, Laboratory of Genetics, La Jolla, California 92037, USA.

Nature Reviews. Neuroscience
|May 20, 2016
PubMed
Summary
This summary is machine-generated.

Induced pluripotent stem cells allow generating diverse human neural cells for studying neurological disorders. This advance has enabled the development of new human cell-based disease models.

More Related Videos

Kinetic Measurement and Real Time Visualization of Somatic Reprogramming
08:56

Kinetic Measurement and Real Time Visualization of Somatic Reprogramming

Published on: July 30, 2016

7.0K
Live Imaging Followed by Single Cell Tracking to Monitor Cell Biology and the Lineage Progression of Multiple Neural Populations
10:55

Live Imaging Followed by Single Cell Tracking to Monitor Cell Biology and the Lineage Progression of Multiple Neural Populations

Published on: December 16, 2017

9.2K

Related Experiment Videos

Last Updated: Mar 21, 2026

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
11:42

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

5.5K
Kinetic Measurement and Real Time Visualization of Somatic Reprogramming
08:56

Kinetic Measurement and Real Time Visualization of Somatic Reprogramming

Published on: July 30, 2016

7.0K
Live Imaging Followed by Single Cell Tracking to Monitor Cell Biology and the Lineage Progression of Multiple Neural Populations
10:55

Live Imaging Followed by Single Cell Tracking to Monitor Cell Biology and the Lineage Progression of Multiple Neural Populations

Published on: December 16, 2017

9.2K

Area of Science:

  • Neuroscience
  • Stem Cell Biology
  • Genetics

Background:

  • Limited access to live human brain cells historically hindered research into neurological disorders and fundamental neuroscientific mechanisms.
  • The advent of induced pluripotent stem cell (iPSC) technology has revolutionized the field by enabling the in vitro generation of various neural cell types from individual human somatic cells.

Purpose of the Study:

  • To highlight the impact of induced pluripotent stem cell technology on creating human neural cell models.
  • To discuss the advancements in generating defined neural cell types for disease modeling.

Main Methods:

  • Reprogramming of somatic human cells into induced pluripotent stem cells.
  • In vitro differentiation of iPSCs into diverse neural cell populations.
  • Direct conversion methods to generate induced neurons.

Main Results:

  • Established methods for generating a wide range of human neural cells from individual donors.
  • Development of robust and defined neural cell types through reprogramming and direct conversion.
  • Creation of various human reprogramming-based neural disease models.

Conclusions:

  • Induced pluripotent stem cell technology provides a powerful platform for studying human neurological disorders.
  • Reprogramming and direct conversion methods have significantly advanced the creation of in vitro human neural disease models.
  • These models offer unprecedented opportunities to elucidate disease mechanisms and test therapeutic strategies.